Days of separation with baby
Release time:
2022-11-14
The first time I separated from you was the day you were born. The second time I separated from you, 2022 8# April 28 , is the day of weaning. Courage today, want to talk to you, mom and you separate these days!
# September 28 , maybe you have no consciousness at all, from this day on, you will not be able to drink breast milk. The baby has to be separated from others. For the first time, my mother slept separately from you. You cried so hard that I was heartbroken. Breastfeeding felt so hard before, but now I don't feel relieved. I only feel lost and unwilling to give up. Goodbye, breast milk for 11 months and 18 days, goodbye, 37 degree constant temperature love, has since broken the closest connection between you and me.
829 , mom went back to the dormitory and saw your toys, socks and clothes. she couldn't control her emotional collapse. Because my mother knows that she can't accompany you every day in the future. She may see you once a week or longer! Since you were born, you and I have not been separated. Your father said that this is a process that every child goes through. I don't know if he is pretending to be confused when he said this sentence. He may think that I feel distressed because of your weaning. In fact, what I care more about is that your mother may be absent at every stage of your growth. I was in a trance for a long time, only to say back to your father, the baby will be at home in the future.
That whole day, I dare not open your photos, videos, surveillance, dare not see everything about you. When I get off work, I just want to be alone, turn off my cell phone, pack up your toys, your clothes, and the necessities of life at home in the future. After tidying up, the whole dormitory was empty in an instant, and the mood could not be calmed down for a long time. I am especially afraid that when I meet you again, you will not know who I am and who loves you very much. Because I have seen such cases before, I am especially afraid that such things will happen to me. It is really my mother's dereliction of duty.
Mom is also working hard to adjust her mentality. You are still behind her, and life will continue. There is still a long way to go. We can only be separated for a while, hoping that this day will not be too long. I suddenly understood that sentence, not the child cannot leave his mother, but the mother cannot leave you. People are lonely after all, and my mother also understands that being separated from you, making you a left-behind child at such a small age will cause you to feel insecure, but now my mother's conditions and abilities are not allowed, so I can only compromise with life.
9January 1 , I went home to see you. I was very excited all the way, but when I got off the bus and called you, you looked blank and probably didn't recognize who I was! Approaching you, you leaned on my shoulder and handed me your hand for me to hug. My heart melted instantly. After talking to you for a while, you haven't forgotten to eat milk, pulling clothes to eat milk. I told you a lot of words, you should not understand, keep crying, dad had to carry you in the past.
tidy up your clothes, toys and some common drugs before leaving. grandpa is told to feed you calcium tablets every day. Everything is almost sorted out, and I have to go again in a hurry. I brought you back from my father and wanted to take you to play with toys, but you pointed to the bathtub to take a bath. Take a good bath, mom say goodbye to you, you whine, perhaps is to realize that mom is leaving ...... life is too much helpless, parting belly sad. In the days to come, I hope my Ruibaobao will become stronger and stronger!
Now I can only get up every day to look at the monitor and see what you are doing! See if you get up and have a good meal, that's all ...
(Gao Youzhi)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31